(Q34232481)

31 July 2017

1 reference

title

Recent advances in melanoma research. (English)

1 reference

31 July 2017

T Saida

1

1 reference

31 July 2017

1 May 2001

1 reference

Journal of Dermatological Science

31 July 2017

1 reference

31 July 2017

26

1 reference

31 July 2017

1-13

1 reference

31 July 2017

1

1 reference

Molecular biology of human melanoma development and progression

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Molecular events in melanoma development and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Familial melanoma; CDKN2A and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Homozygous deletions within human chromosome band 9p21 in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A ( P16INK4A ) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Germline p16 mutations in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Ras mutations in human melanoma: a marker of malignant progression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Absence of p53 gene mutations in cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Stabilization of beta-catenin by genetic defects in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Loss of beta-catenin expression associated with disease progression in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Matrix metalloproteinases in human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Moesin and CD44 expression in cutaneous melanocytic tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Increased synthesis of hyaluronate enhances motility of human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Prognostic value of tumour vascularity in primary melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Human malignant melanoma cells release a factor that inhibits the expression of smooth muscle alpha-actin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Updated statistical data for malignant melanoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Malignant melanoma on the sole: how to detect the early lesions efficiently.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

A new American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

What is the most promising strategy for the treatment of metastasizing melanoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Combination of chemotherapy with interleukin-2 and interferon alfa for the treatment of metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

T cell immune responses against melanoma and melanocytes in cancer and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Sensitivity to extrinsically supplied interferon and the endogenous expression of interferon in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2801%2900085-8

7 January 2021

10.1016/S0923-1811(01)00085-8

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11323215